Ireland's Life Sciences Boom Is Creating a Talent Bottleneck

Ireland is riding a wave of life sciences growth. Multinational pharmaceutical and biotech companies continue to invest heavily in Irish manufacturing sites, from cutting-edge biologics and vaccine production to the country’s first commercial-scale gene therapy facility. The result? A sector in rapid expansion - bringing opportunity, innovation, and significant demand for skilled professionals.

But with this boom comes a growing challenge: talent shortages. As the scale and sophistication of Irish manufacturing increases, so too does the pressure on its workforce. Hiring the right people - fast - has become a critical concern for companies looking to stay competitive, compliant, and operational.

In this blog, we explore what’s driving Ireland’s life sciences growth, how the talent bottleneck is affecting manufacturers, and what businesses can do to overcome it.

Ireland’s Manufacturing Momentum

Ireland has long been a strategic location for life sciences, with strong government support, a highly regarded regulatory environment, and a reputation for quality manufacturing. But recent developments have pushed this momentum to new heights.

Over €1 billion has been invested into Irish pharma and biotech facilities in just the past few year years. Some of the major projects include:

• Merck & Co. (MSD) acquired WuXi Biologics’ vaccine facility in Dundalk for approximately $500 million (Jan 2025), expanding its global vaccine manufacturing capabilities and preserving 200+ jobs.

• Eli Lilly committed $1.8 billion to Ireland in 2024, with major expansions at Kinsale for diabetes and obesity therapeutics, and Limerick for biologics production, including Alzheimer’s treatment.

• GE Healthcare announced a €132 million expansion at its Carrigtwohill site in Cork (Jan 2025), increasing its capacity for contrast media by 25 million doses per year.

• BioMarin is investing €60 million into its Shanbally facility in Cork (Dec 2024), expanding its research and clinical supply manufacturing—its largest site outside the U.S.

These investments are driving demand across the supply chain - from upstream manufacturing to quality control, validation, and tech transfer. While this presents huge economic and scientific potential, it’s also creating a serious pressure point: not enough people to do the work.

The Talent Bottleneck: What’s Happening?

As life sciences manufacturing grows in both volume and complexity, the need for highly skilled, experienced professionals is intensifying. The challenge isn’t just about filling jobs - it’s about finding people who understand the specific demands of GMP-regulated environments, and who can operate in cleanrooms, labs, and production suites with high levels of compliance and precision.

This bottleneck is being felt in several ways:

1. Longer Time-to-Hire

Companies are reporting extended lead times to fill key positions. Delays in hiring can slow down facility launches, hinder batch release, and impact production schedules - especially when trying to scale a site quickly.

2. Limited Local Talent Pools

Ireland’s talent pool is highly skilled, but relatively small. As more companies set up shop or expand operations, the competition for talent is intensifying. In some cases, multiple employers are recruiting for similar roles in the same region, driving up demand and stretching availability.

3. Shortages in Senior and Specialist Roles

While graduate and entry-level pathways are being built up, there’s still a shortage of professionals with five to ten years’ experience in specialist areas. These mid-to-senior-level individuals are often critical to site ramp-ups, audits, or regulatory approvals - and they’re becoming harder to find.

Why the Shortage Matters

In life sciences manufacturing, talent isn’t just a resource - it’s a regulatory requirement. Every role in the chain plays a part in ensuring that products are safe, effective, and delivered to patients without delay.

Without the right people:

• Projects miss key milestones.

• Quality and compliance risks increase.

• Production capacity is underused.

• Innovation pipelines are slowed.

• Cost-efficiency suffers.

For Ireland to maintain its global reputation, and for companies to capitalise on their investment, solving the talent gap isn’t optional - it’s essential.

What’s Being Done?

To their credit, industry and government bodies are taking action.

• Education and training providers, including NIBRT and Technological University Dublin, are expanding their course offerings in biologics, CGT, and GMP operations.

• IDA Ireland continues to support workforce development through funding initiatives and regional investment strategies.
• Companies themselves are launching in-house training academies, apprenticeships, and graduate programmes to build their own talent pipelines.

These are positive steps. But developing talent takes time - and the current rate of growth demands a faster solution.

How We Help Bridge the Gap

At Thor Companies, we specialise in connecting life sciences organisations with the talent they need to grow.

We understand the unique demands of manufacturing in GMP-regulated environments, and we’ve built deep networks of professionals who can hit the ground running in these settings. Whether you’re building a new team from scratch or searching for that one critical hire, we’re here to make the process faster, smoother, and more reliable.

Here’s how we support our clients:

• Speed-to-hire: Our team works quickly to identify and shortlist qualified candidates, reducing downtime and project delays.

• Market knowledge: We stay close to the industry and know where skills are emerging, what salaries are shifting, and how to position roles competitively.

• Partnership approach: We don’t just fill roles - we support workforce strategy. Whether you’re scaling a site or planning future headcount, we’re part of the conversation.

Final Thoughts

Ireland’s life sciences manufacturing boom is one of the most exciting stories in global pharma. The combination of innovation, investment, and infrastructure is positioning the country at the forefront of next-generation therapeutics.

But talent is the engine that drives it all.

To fully realise this opportunity, companies must be prepared to compete for - and invest in - the people who will bring these therapies to life. That means thinking beyond traditional hiring methods, expanding search parameters, and working with partners who understand the complexity of the sector.

If you’re growing your team or planning for the next phase of expansion, our specialist consultants are ready to help.

Need support with your hiring plans?
Whether you're scaling a new site, replacing critical staff, or preparing for future growth, our specialist life sciences consultants can help you find the talent you need - fast.

Get in touch with us today.